BiotechTube

MEDI3250 + Placebo

Phase 3Completed
1 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Healthy Japanese Children Age 7 Years Through 18 Years

Conditions

Healthy Japanese Children Age 7 Years Through 18 Years

Trial Timeline

Oct 1, 2014 → Apr 1, 2015

NCT ID
NCT02269475

About MEDI3250 + Placebo

MEDI3250 + Placebo is a phase 3 stage product being developed by AstraZeneca for Healthy Japanese Children Age 7 Years Through 18 Years. The current trial status is completed. This product is registered under clinical trial identifier NCT02269475. Target conditions include Healthy Japanese Children Age 7 Years Through 18 Years.

What happened to similar drugs?

20 of 20 similar drugs in Healthy Japanese Children Age 7 Years Through 18 Years were approved

Approved (20) Terminated (1) Active (0)
✅mRNA-1273.712ModernaApproved
✅Cholestyramine + Colesevelam HClDaiichi SankyoApproved
✅Cholestyramine + Cholestyramine + TangDaiichi SankyoApproved
✅Olmesartan medoxomil + Irbesartan + ValsartanDaiichi SankyoApproved
✅Perampanel 6 MGEisaiApproved
✅eszopiclone, zolpidem, placeboSumitomo PharmaApproved
✅Listerine Experimental Mouthwash + Colgate Cavity Protection Toothpaste + Listerine Total Care ZeroJohnson & JohnsonApproved

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT02269475Phase 3Completed

Competing Products

20 competing products in Healthy Japanese Children Age 7 Years Through 18 Years

See all competitors
ProductCompanyStageHype Score
Use of Wearable Digital Sensors After mRNA Vaccination in AdultsModernaPreclinical
0
mRNA-0184ModernaPhase 1
0
mRNA-6231ModernaPhase 1
0
LetrozoleDr. Reddy's LaboratoriesPhase 1
26
IsotretinoinDr. Reddy's LaboratoriesPhase 1
26
FexofenadineDr. Reddy's LaboratoriesPhase 1
26
SertralineDr. Reddy's LaboratoriesPhase 1
26
Nizatidine + AxidDr. Reddy's LaboratoriesPhase 1
26
AnastrozoleDr. Reddy's LaboratoriesPhase 1
26
mRNA-1273.712ModernaApproved
0
RisperidoneDr. Reddy's LaboratoriesPhase 1
26
LamotrigineDr. Reddy's LaboratoriesPhase 1
26
Metformin + GlucophageDr. Reddy's LaboratoriesPhase 1
26
LamotrigineDr. Reddy's LaboratoriesPhase 1
26
mRNA-0184ModernaPhase 1
0
Divalproex SodiumDr. Reddy's LaboratoriesPhase 1
26
SirolimusDr. Reddy's LaboratoriesPhase 1
26
GlimepirideDr. Reddy's LaboratoriesPhase 1
26
Ziprasidone HydrochlorideDr. Reddy's LaboratoriesPhase 1
26
Naproxen sodiumDr. Reddy's LaboratoriesPhase 1
26